Philip Liptrot is an extensively experienced Lead Medical Science Liaison (MSL), specializing in heart failure, cardio-renal conditions, and cardiac amyloidosis, with over 20 years in the pharmaceutical industry. They began their career in sales, promoting cardiology and diabetes products, and transitioned to the Medical Department at Servier Labs as a Medical Liaison Specialist. Philip has held significant roles at Takeda and Novartis, contributing to major product launches and pre-launch activities. Currently, they serve as a Medical Strategy Manager at Bayer Global, focusing on heart failure strategies, while also holding a Master's in Medicinal Chemistry, completed in 2018. Philip is dedicated to enhancing collaboration between pharmaceutical companies and healthcare professionals to improve patient outcomes.
This person is not in the org chart
This person is not in any teams
This person is not in any offices